Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta
- PMID: 25342107
- PMCID: PMC5644846
- DOI: 10.1159/000368429
Structural and Metabolic Effects of Obesity on the Myocardium and the Aorta
Abstract
Obesity per se is a recognized risk factor for cardiovascular disease exerting independent adverse effects on the cardiovascular system. Despite this well documented link, the mechanisms by which obesity modulates cardiovascular risk are not well understood. Obesity is linked to a wide variety of cardiac changes, from subclinical diastolic dysfunction to end stage systolic heart failure. In addition, obesity causes changes in cardiac metabolism that make ATP production and utilization less efficient producing functional consequences that are linked to the increased rate of heart failure in this population. This review focuses on the cardiovascular structural and metabolic remodelling that occurs in obesity with and without co-morbidities and the potential links to increased mortality in this population. © 2014 S. Karger GmbH, Freiburg.
Similar articles
-
Myocardial substrate metabolism in obesity.Int J Obes (Lond). 2013 Jul;37(7):972-9. doi: 10.1038/ijo.2012.170. Epub 2012 Oct 16. Int J Obes (Lond). 2013. PMID: 23069666 Review.
-
Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.Curr Obes Rep. 2016 Dec;5(4):424-434. doi: 10.1007/s13679-016-0235-6. Curr Obes Rep. 2016. PMID: 27744513 Review.
-
[Obesity and cardiac failure].Arch Mal Coeur Vaiss. 2005 Jan;98(1):39-45. Arch Mal Coeur Vaiss. 2005. PMID: 15724418 Review. French.
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
-
The incremental prognostic value of echocardiography in asymptomatic stage a heart failure.J Am Soc Echocardiogr. 2010 Oct;23(10):1025-34. doi: 10.1016/j.echo.2010.06.017. Epub 2010 Jul 24. J Am Soc Echocardiogr. 2010. PMID: 20659788
Cited by
-
Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.J Cardiovasc Magn Reson. 2017 Oct 25;19(1):81. doi: 10.1186/s12968-017-0397-8. J Cardiovasc Magn Reson. 2017. PMID: 29070069 Free PMC article.
-
Effects of exercise and L-arginine intake on inflammation in aorta of high-fat diet induced obese rats.J Exerc Nutrition Biochem. 2016 Mar 31;20(1):36-40. doi: 10.20463/jenb.2016.03.20.1.6. J Exerc Nutrition Biochem. 2016. PMID: 27298811 Free PMC article.
-
Relationship between overweight and obesity and cardiac dimensions and function in a paediatric population.Eur J Pediatr. 2022 May;181(5):1943-1949. doi: 10.1007/s00431-022-04384-0. Epub 2022 Jan 25. Eur J Pediatr. 2022. PMID: 35075570
-
Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy.Cardiovasc Diagn Ther. 2020 Jun;10(3):559-567. doi: 10.21037/cdt-19-587. Cardiovasc Diagn Ther. 2020. PMID: 32695637 Free PMC article.
-
The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.Nutrients. 2020 Sep 17;12(9):2847. doi: 10.3390/nu12092847. Nutrients. 2020. PMID: 32957558 Free PMC article. Review.
References
-
- Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–778. - PubMed
-
- Alpert MA. Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001;321:225–236. - PubMed
-
- Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001;38:429–433. - PubMed
-
- Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 1988;108:7–13. - PubMed
-
- Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–341. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources